DeutschNewstral
Article
jdsupra.com on 2017-12-22 15:42
2017 Biosimilar Approvals in Europe
Related news
- US Biosimilar Approvals Soar in 2017jdsupra.com
- Mundipharma Launches Pegfilgrastim Biosimilar in Europejdsupra.com
- How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline (Updated)jdsupra.com
- How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipelinejdsupra.com
- Update on Biosimilar Approvals and Pending Applications in Europe and the U.S.jdsupra.com
- Celltrion’s Herceptin Biosimilar Submitted For Approval in Europejdsupra.com
- Recent Biosimilar Approvalsjdsupra.com
- Samsung Bioepis Seeks Regulatory Approval for an Adalimumab Biosimilar in Europe and South Koreajdsupra.com
- Enbrel Biosimilar in Europe and USjdsupra.com
- Biosimilar Approval Updates in Europe and Chinajdsupra.com
- PAmgen launches Humira biosimilar in Europepacbiztimes.com
- CVS to Replace Two Brand-Name Biologics with Follow-on/Biosimilar Products in 2017jdsupra.com
- Merck Launches Ontruzant®, First Trastuzumab Biosimilar in Europejdsupra.com
- Sanofi Receives Positive Opinion for Insulin Aspart Biosimilar in Europejdsupra.com
- Alvotech and STADA Launch HUKYNDRA® (Biosimilar of HUMIRA®) in Europejdsupra.com
- STADA and Xbrane Announce Approval of Ranibizumab Biosimilar in Europejdsupra.com
- Teva Receives Approval for First Ophthalmology Biosimilar in Europejdsupra.com
US Crypto Exchange Kraken Wins ‘Milestone’ Regulatory Approvals in Europenews.bitcoin.com- Rituximab Biosimilar Updates from Europejdsupra.com